Higher MMP2 expression may lead to increased severity of chronic atrophic gastritis and subsequently less acid reflux and decreased EA risk (Sozzi et al, 1998; Raghunath et al, 2003; Bergin et al, 2004). This evidence concerns the gene MMP2 and gastroesophageal reflux disease.